Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 4068252, 2 pages

Omics Landscape in Disease Biomarkers Discovery

1Victor Babes National Institute of Pathology, Bucharest, Romania
2Faculty of Biology, University of Bucharest, Bucharest, Romania
3Skin Cancer Unit, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy
4University of Turin, Turin, Italy

Received 22 September 2016; Accepted 22 September 2016

Copyright © 2016 Monica Neagu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Neagu, R. Albulescu, and C. Tanase, “Biotechnology landscape in cancer drug discovery,” Future Science OA, vol. 1, no. 3, pp. 1–4, 2015. View at Publisher · View at Google Scholar
  2. C. Tanase, R. Albulescu, and M. Neagu, “Proteomic approaches for biomarker panels in cancer,” Journal of Immunoassay and Immunochemistry, vol. 37, no. 1, pp. 1–15, 2016. View at Publisher · View at Google Scholar · View at Scopus